| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 05/13/2008 | US7371535 Detect binding with cells transfected with DNA |
| 05/13/2008 | US7371374 Neural transplantation using pluripotent neuroepithelial cells |
| 05/13/2008 | US7371257 Stent lining |
| 05/13/2008 | US7371207 Estrogen receptor α regulated gene expression, related assays and therapeutics |
| 05/13/2008 | CA2438169C Modulated release particles for aerosol delivery |
| 05/13/2008 | CA2336261C Cyclin e2 genes and proteins |
| 05/13/2008 | CA2315239C Nucleotide and protein sequence of mammastatin and methods of use |
| 05/08/2008 | WO2008054826A2 Pathotropic targeted gene delivery system for cancer and other disorders |
| 05/08/2008 | WO2008054770A2 Use of tumor necrosis factor-alpha p75 receptor for the reduction of inflammation |
| 05/08/2008 | WO2008054711A2 Combined telomerase inhibitor and gemcitabine for the treatment of cancer |
| 05/08/2008 | WO2008054561A2 Proteins, nucleic acids encoding the same and associated methods of use |
| 05/08/2008 | WO2008054466A2 Delivery of biologically active materials using core-shell tecto (dendritic polymers) |
| 05/08/2008 | WO2008054184A1 Composition for treatment of cervix cancer |
| 05/08/2008 | WO2008053988A1 Method of producing microcapsules |
| 05/08/2008 | WO2008053909A1 Agent for controlling growth and/or differentiation of mesenchymal stem cell |
| 05/08/2008 | WO2008053892A1 Pharmaceutical for promoting functional regeneration of damaged tissue |
| 05/08/2008 | WO2008035365A8 Rna interference mediated inhibition of aurorakinase b and its combinations as anticancer therapy |
| 05/08/2008 | WO2008031899A3 Oligonucleotide non-viral delivery systems |
| 05/08/2008 | WO2007107789A3 Treatment of cns conditions |
| 05/08/2008 | WO2007067733A3 Compositions and methods to monitor rna delivery to cells |
| 05/08/2008 | WO1999048916A8 Hypoxia-inducible human genes, proteins, and uses thereof |
| 05/08/2008 | US20080108803 Functional and hyperfunctional siRNA directed against Bcl-2 |
| 05/08/2008 | US20080108802 Functional and hyperfunctional siRNA directed against Bcl-2 |
| 05/08/2008 | US20080108801 Conjugated lipophilic group with a modified nucleotide is used to target disease gene, cells, tissue, for drug delivery to entrance into tumor cells; ribose sugar of nucleotide is replaced with a cyclic carrier which has at least one attached phosphate or phosphorothioate group; antitumor biodrugs |
| 05/08/2008 | US20080108788 Cell surface receptor for use as tool in identifying modulators of vascular pressure |
| 05/08/2008 | US20080108585 Dna vaccination for treatment of autoimmune disease |
| 05/08/2008 | US20080108582 Methods And Compositions For Combinatorial Approaches To Cancer Gene Therapy |
| 05/08/2008 | US20080108581 consist of DNA sequence-specific ligand capable of recognizing sequence common to genes of pathological interest ( as IGF-1, IGF-1R, VEGF, BCL2), linker arm, and topoisomerase I posion (as camptothecins, rebeccamycins, minor groove ligands, benzimidazoles); dismetabolic, autoimmune diseases, HIV and HCV |
| 05/08/2008 | US20080108567 Leptin-related peptides |
| 05/08/2008 | US20080108139 Composition of matter comprising primary nucleic acid component |
| 05/08/2008 | US20080107714 Use of a vector comprising a nucleic acid encoding an anti-angiogenic factor for the treatment of corneal neovascularization |
| 05/08/2008 | US20080107693 Hybrid or chimeric polynucleotides, proteins, and compositions comprising hepatitis B virus sequences |
| 05/08/2008 | US20080107668 Oligopeptides comprising epitopic sequences for use in induction of killer lymphocyte response in treatment of cell proliferative disorders |
| 05/08/2008 | US20080107633 Cultures of human CNS neural stem cells |
| 05/08/2008 | US20080107631 Liquid mixture comprising cryoprotectants and lyoprotectants for use in long term storage of viral particles |
| 05/08/2008 | US20080107627 Use of sarp-1 for the treatment and/or prevention of scleroderma |
| 05/08/2008 | US20080107620 Human Cytomegalovirus Immunotherapy |
| 05/08/2008 | US20080107605 From a clone comprising complete nucleotide sequence for the expression of the TSH |
| 05/08/2008 | US20080107604 Method for the Prediction of the Risk Potential for Cancerous Diseases and Inflammatory Intestinal Diseases and Corresponding Tests |
| 05/08/2008 | US20080105961 Ligands of the Molecule Fit (Agt-121) and their Pharmaceutical Use |
| 05/08/2008 | DE102006051516A1 (Basen-)modifizierte RNA zur Expressionssteigerung eines Proteins (Base-) modified RNA to increase in expression of a protein |
| 05/08/2008 | CA2668285A1 Pathotropic targeted gene delivery system for cancer and other disorders |
| 05/08/2008 | CA2667970A1 Monoclonal antibodies and fragment thereof directed against the human anti-mullerian hormone type ii receptor (amhr-ii) |
| 05/08/2008 | CA2636788A1 Pharmaceuticals that promote functional regeneration of damaged tissues |
| 05/08/2008 | CA2634783A1 Anti-hyperproliferative therapies targeting hdgf |
| 05/07/2008 | EP1918380A2 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof |
| 05/07/2008 | EP1918377A1 Mammalian cytokine receptor subunit proteins, related reagents and methods |
| 05/07/2008 | EP1918373A1 Anti-obesity agent and anti-obesity food |
| 05/07/2008 | EP1918366A1 Pleuripotent stem cells generated from adipose tissue-derived stromal cells and uses thereof |
| 05/07/2008 | EP1918304A1 Monoclonal antibodies against the human anti-müllerian hormone type II receptor (AMHR-II) |
| 05/07/2008 | EP1917975A1 Novel proteins in Enteroaggregative Escherichia Coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 05/07/2008 | EP1917021A2 Methods for the treatment of anxiety and for identification of anxiolytic agents |
| 05/07/2008 | EP1817060A4 Mda-7 protein variants having antiproliferative activity |
| 05/07/2008 | EP1601682B1 Compositions and methods for diagnosing prostate cancer |
| 05/07/2008 | EP1519755B1 Stinging cells expressing an exogenous polynucleotide encoding a therapeutic, diagnostic or a cosmetic agent and methods compositions and devices utilizing such stinging cells or capsules derived therefrom for delivering the therapeutic, diagnostic or cosmetic agent into a tissue |
| 05/07/2008 | EP1509250B1 Methods compositions and articles of manufacture for modulating bone growth |
| 05/07/2008 | EP1417308B1 Human protooncogene kg-20 and protein encoded therein |
| 05/07/2008 | EP1380593B1 Soluble rage protein |
| 05/07/2008 | EP1126028B1 Novel g protein-coupled receptor proteins, dnas thereof and ligands to the same |
| 05/07/2008 | EP1059929B1 Isolated stromal cells for use in the treatment of diseases of the central nervous system |
| 05/07/2008 | EP1015470A4 Composition and method for delivery of nucleic acids |
| 05/07/2008 | EP0991758B1 Smad6 and uses thereof |
| 05/07/2008 | EP0956299B1 Peptide antagonists of dp transcription factors |
| 05/07/2008 | EP0764213B1 Vectors encoding recombinant aav genomes |
| 05/07/2008 | CN101175509A Immunogenic compositions comprising lawsonia intracellularis |
| 05/07/2008 | CN101173922A Gpr54 knock-out mammals and screening methods using them |
| 05/07/2008 | CN101173301A Construction method for pacemaking channels gene hypotype HCN4 recombined retroviral vector |
| 05/07/2008 | CN101173299A Construction and application of tumour targeting gonad correlation viral vectors |
| 05/07/2008 | CN101173295A Compositions and methods for identifying antigens which elicit an immune response |
| 05/07/2008 | CN101173294A Gene tiny chain carrier, construction method and application of the same |
| 05/07/2008 | CN101173290A Chemically synthesized HSV1 virus gB glucoprotein extracellular region gene fragment, representation and application of the same |
| 05/07/2008 | CN101173284A Mouse anti-human ester polyoses acceptor antibody chain variable region gene and use thereof |
| 05/07/2008 | CN101173283A Mouse anti-human ester polyoses acceptor antibody heavy chain variable region gene and use thereof |
| 05/07/2008 | CN101173282A Synthetic gene encoding human epidermal growth factor 2/neu antigen and uses thereof |
| 05/07/2008 | CN101173278A Ankylosing spondylitis pathopoiesia correlation gene IRS-1 mutant gene, detecting method and reagent kit thereof |
| 05/07/2008 | CN101172998A BASB111 polypeptide and polynucleotide from |
| 05/07/2008 | CN101172994A Small disturbance RNA of interleukin 17 acceptor mIL-17RE gene, encoding gene and application of the same |
| 05/07/2008 | CN101172158A Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26 |
| 05/07/2008 | CN100386435C Small interfering RNA for suppressing multiple effect growth factor expression and its uses |
| 05/06/2008 | USRE40300 Carbon dioxide enhancement of inhalation therapy |
| 05/06/2008 | US7368559 FcγRIIA-specific nucleic acid interference |
| 05/06/2008 | US7368557 Comprises DNA from RNA virus which codes for RNA polymerase and nonstructural protein in bacterial artificial chromosome; virions; gene therapy |
| 05/06/2008 | US7368553 nucleotide sequences comprising cDNA and genomic DNA that code for angiogenesis factors, used for gene therapy |
| 05/06/2008 | US7368551 De novo DNA cytosine methyltransferase genes, polypeptides and uses thereof |
| 05/06/2008 | US7368545 PCA3 messenger RNA species in benign and malignant prostate tissues |
| 05/06/2008 | US7368535 CD200 receptors |
| 05/06/2008 | US7368532 A non-toxic polypeptide containing a binding domain that binds to the neuronal cell and a translocation domain that translocates the therapeutic agent into the neuronal cell; clostridial neurotoxins |
| 05/06/2008 | US7368436 Testosterone-repressed prostate message-2 (TRPM-2); delaying progression of prostatic tumor cells to an androgen-independent state |
| 05/06/2008 | US7368261 Conserved Neisserial antigens |
| 05/06/2008 | US7368257 Using b-cell receptors as tool in identifying modulators for prevention and treatment of inflammation, autoimmune, transplant rejection and cancer disorders |
| 05/06/2008 | US7368255 Nucleotide sequences coding transcription factor associated with tumor suppressor activity for use in treatment and prevention of cell proliferative disorders |
| 05/06/2008 | US7368244 Expressed by keratinocytes, wound-healing and chondrosarcoma tissue; nucleic acids comprising polynucleotide of given sequence; use in diagnostics and therapeutics |
| 05/06/2008 | US7368116 Method of enhancing a targeted immune response against tumors |
| 05/06/2008 | US7368113 Hormonally up-regulated, neu-tumor-associated kinase |
| 05/06/2008 | US7368107 Tumor antigen peptides derived from cyclophilin B |
| 05/06/2008 | US7368098 Use of biomolecular targets in the treatment and visualization of tumors |
| 05/06/2008 | US7367688 Outdoor lighting lamp with water-resistant cover |
| 05/06/2008 | CA2142746C Rev-independent hiv expression and replication |
| 05/02/2008 | WO2008051306A1 Soluble tnf receptors and their use in treatment of disease |
| 05/02/2008 | WO2008050898A1 PARTIAL FRAGMENT OF REIC/Dkk-3 GENE AND THERAPEUTIC AGENT FOR CANCER CONTAINING THE SAME |